dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp06875

General Description

Peptide name : RR-1-R

Source/Organism : Synthetic analogue of LfcinB(21-25)Pal

Linear/Cyclic : Linear

Chirality : L

Sequence Information

Sequence : RRWQWRWQWR

Peptide length: 10

C-terminal modification: Linear

N-terminal modification : Amidation

Non-natural peptide information:

Activity Information

Assay type : MTT assay

Assay time : 24-h

Activity : IC50 = 68 µM

Cell line : MCF-7

Cancer type : Breast Cancer

Other activity : Antibacterial and Anticancer

Physicochemical Properties

Amino acid composition bar chart :

Molecular mass : 1643.8561 Dalton

Aliphatic index : 0

Instability index : 180.84

Hydrophobicity (GRAVY) : -2.86

Isoelectric point : 12

Charge (pH 7) : 3.7601

Aromaticity : 40

Molar extinction coefficient (cysteine, cystine): (0, 0)

Hydrophobic/hydrophilic ratio : 0.6667

hydrophobic moment : -0.036

Missing amino acid : A,C,D,E,F,G,H,I,K,L,M,N,P,S,T,V,Y

Most occurring amino acid : R

Most occurring amino acid frequency : 4

Least occurring amino acid : Q

Least occurring amino acid frequency : 2

Structural Information

3D structure :

Secondary structure fraction (Helix, Turn, Sheet): (0, 0, 40)

SMILES Notation: N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O

Secondary Structure :

Method Prediction
GOR HHHHHHHHHH
Chou-Fasman (CF) CEEEEEECCC
Neural Network (NN) HHHHHHHCCC
Joint/Consensus HHHHHHHCCC

Molecular Descriptors and ADMET Properties

Molecular Descriptors: Click here to download

ADMET Properties: Click here to download

Cross Referencing databases

Pubmed Id : 36687035.0

Uniprot : Not available

PDB : Not available

CancerPPD : Not available

ApIAPDB : Not available

CancerPPD2 ID: 7471

Reference

1 : Barragán-Cárdenas AC, et al. Changes in Length and Positive Charge of Palindromic Sequence RWQWRWQWR Enhance Cytotoxic Activity against Breast Cancer Cell Lines. ACS Omega. 2023; 8:2712-2722. doi: 10.1021/acsomega.2c07336

Literature

Paper title : Changes in Length and Positive Charge of Palindromic Sequence RWQWRWQWR Enhance Cytotoxic Activity against Breast Cancer Cell Lines.

Doi : https://doi.org/10.1021/acsomega.2c07336

Abstract : Breast cancer is one of the main causes of premature death in women; current treatments have low selectivity, generating strong physical and psychological sequelae. The palindromic peptide R-1-R (RWQWRWQWR) has cytotoxic activity against different cell lines derived from cancer and selectivity against noncancerous cells. To determine if changes in the charge/length of this peptide increase its activity, six peptides were obtained by SPPS, three of them with addition of Arg at the N, C-terminal or both and three with deletion of Arg at the N, C-terminal or both. The cytotoxic and selective activities were evaluated against MCF-7, MDA-MB-231, and MCF-12 cell lines and fibroblast primary cell culture, evidencing that the RR-1-R peptide with the inclusion of Arg in the N-terminal end maintained selectivity and increased cytotoxicity against lines derived from breast cancer. The effect of this addition regarding the type of induced cell death was evaluated by flow cytometry, showing very low rates of necrosis and a significant majority of apoptotic events with activation of both Caspase 8 and Caspase 9. This work allowed us to find a modification that generates a peptide with greater cytotoxic effects and can be considered a promising molecule for other approaches to improve anticancer peptides.